Class information for: |
Basic class information |
Hierarchy of classes |
The table includes all classes above and classes immediately below the current class. |
| Cluster id | Level | Cluster label | #P |
|---|---|---|---|
| 0 | 4 | ONCOLOGY//CELL BIOLOGY//BIOCHEMISTRY & MOLECULAR BIOLOGY | 2934640 |
| 273 | 3 | P GLYCOPROTEIN//MULTIDRUG RESISTANCE//DRUG METABOLISM AND DISPOSITION | 43782 |
| 1763 | 2 | JOURNAL OF PHARMACOKINETICS AND BIOPHARMACEUTICS//CACO 2//BIOPHARMACEUTICS & DRUG DISPOSITION | 6737 |
| 38296 | 1 | FRACTIONATED H 3HEPARIN//PHARMACEUT SCI BIOPHARMACEUT MIZUHO KU//RAT PARENCHYMAL HEPATOCYTE | 65 |
Terms with highest relevance score |
| rank | Category | termType | chi_square | shrOfCwithTerm | shrOfTermInClass | termInClass |
|---|---|---|---|---|---|---|
| 1 | FRACTIONATED H 3HEPARIN | authKW | 4363912 | 14% | 100% | 9 |
| 2 | PHARMACEUT SCI BIOPHARMACEUT MIZUHO KU | address | 3030487 | 15% | 63% | 10 |
| 3 | RAT PARENCHYMAL HEPATOCYTE | authKW | 1454637 | 5% | 100% | 3 |
| 4 | PROTEIN MEDIATED TRANSPORT | authKW | 969758 | 3% | 100% | 2 |
| 5 | SCAVENGER LIKE RECEPTOR | authKW | 969758 | 3% | 100% | 2 |
| 6 | LIVER PARENCHYMAL CELL | authKW | 775802 | 6% | 40% | 4 |
| 7 | 31 TANABE DORIMIZUHO KU | address | 727316 | 5% | 50% | 3 |
| 8 | PHARMACEUT SCI BIOPHARMACEUT | address | 623413 | 5% | 43% | 3 |
| 9 | ALPHA GLOBULIN | authKW | 517199 | 6% | 27% | 4 |
| 10 | DOSE DEPENDENT UPTAKE | authKW | 484879 | 2% | 100% | 1 |
Web of Science journal categories |
| chi_square_rank | Category | chi_square | shrOfCwithTerm | shrOfTermInClass | termInClass |
|---|---|---|---|---|---|
| 1 | Pharmacology & Pharmacy | 1858 | 95% | 0% | 62 |
| 2 | Chemistry, Medicinal | 696 | 31% | 0% | 20 |
| 3 | Chemistry, Multidisciplinary | 106 | 28% | 0% | 18 |
| 4 | Physiology | 7 | 5% | 0% | 3 |
| 5 | Microbiology | 1 | 3% | 0% | 2 |
| 6 | Pathology | 1 | 2% | 0% | 1 |
| 7 | Gastroenterology & Hepatology | 0 | 2% | 0% | 1 |
| 8 | Infectious Diseases | 0 | 2% | 0% | 1 |
| 9 | Toxicology | 0 | 2% | 0% | 1 |
| 10 | Medicine, Research & Experimental | 0 | 2% | 0% | 1 |
Address terms |
| chi_square_rank | term | chi_square | shrOfCwithTerm | shrOfTermInClass | termInClass |
|---|---|---|---|---|---|
| 1 | PHARMACEUT SCI BIOPHARMACEUT MIZUHO KU | 3030487 | 15% | 63% | 10 |
| 2 | 31 TANABE DORIMIZUHO KU | 727316 | 5% | 50% | 3 |
| 3 | PHARMACEUT SCI BIOPHARMACEUT | 623413 | 5% | 43% | 3 |
| 4 | DEV S EDOGAWA KU | 242439 | 2% | 50% | 1 |
| 5 | HOSP PHARM 2630 SUGITANI | 242439 | 2% | 50% | 1 |
| 6 | ATHEROTHROMBOT TROMSO | 44078 | 2% | 9% | 1 |
| 7 | PHARMACEUT SCI TSUSHIMA NAKA 111 | 44078 | 2% | 9% | 1 |
| 8 | PHARMACEUT SCI MIZUHO KU | 2619 | 2% | 1% | 1 |
| 9 | BIOPHARMACEUT | 1920 | 5% | 0% | 3 |
| 10 | INTER PROGRAM NEUROSCI | 1892 | 2% | 0% | 1 |
Journals |
| chi_square_rank | term | chi_square | shrOfCwithTerm | shrOfTermInClass | termInClass |
|---|---|---|---|---|---|
| 1 | JOURNAL OF PHARMACOBIO-DYNAMICS | 58384 | 22% | 1% | 14 |
| 2 | BIOLOGICAL & PHARMACEUTICAL BULLETIN | 12513 | 23% | 0% | 15 |
| 3 | ARZNEIMITTEL-FORSCHUNG/DRUG RESEARCH | 4162 | 9% | 0% | 6 |
| 4 | CHEMICAL & PHARMACEUTICAL BULLETIN | 3393 | 17% | 0% | 11 |
| 5 | PHARMACEUTISCH WEEKBLAD-SCIENTIFIC EDITION | 850 | 2% | 0% | 1 |
| 6 | DRUG DELIVERY | 353 | 2% | 0% | 1 |
| 7 | ARZNEIMITTELFORSCHUNG-DRUG RESEARCH | 293 | 2% | 0% | 1 |
| 8 | PHARMACEUTICAL RESEARCH | 235 | 3% | 0% | 2 |
| 9 | ARCHIVES INTERNATIONALES DE PHARMACODYNAMIE ET DE THERAPIE | 213 | 2% | 0% | 1 |
| 10 | RESEARCH COMMUNICATIONS IN CHEMICAL PATHOLOGY AND PHARMACOLOGY | 210 | 2% | 0% | 1 |
Author Key Words |
Core articles |
The table includes core articles in the class. The following variables is taken into account for the relevance score of an article in a cluster c: (1) Number of references referring to publications in the class. (2) Share of total number of active references referring to publications in the class. (3) Age of the article. New articles get higher score than old articles. (4) Citation rate, normalized to year. |
Classes with closest relation at Level 1 |